Minerva Neurosciences (NERV) Interest Coverage Ratio (QoQ) (2014 - 2026)
Minerva Neurosciences (NERV) Interest Coverage Ratio (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.88% |
| Dec 31, 2023 | 98.74% |
| Sep 30, 2023 | -162.24% |
| Dec 31, 2022 | 99.32% |
| Sep 30, 2021 | 93.17% |
| Jun 30, 2021 | -377.57% |
| Mar 31, 2021 | 22.86% |
| Dec 31, 2020 | -200.73% |
| Sep 30, 2020 | -135.56% |
| Jun 30, 2020 | 1,949.66% |
| Mar 31, 2020 | 98.89% |
| Dec 31, 2019 | -52,376.82% |
| Sep 30, 2019 | 90.47% |
| Jun 30, 2019 | -838.57% |
| Sep 30, 2018 | 66.32% |
| Jun 30, 2018 | 99.29% |
| Mar 31, 2018 | -184.61% |
| Dec 31, 2017 | 8,815.04% |
| Sep 30, 2017 | -82.66% |
| Jun 30, 2017 | 98.20% |